Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.8 |
mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.019 | 0.8 |
mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |